Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
VectorY Therapeutics
Biotech
VectorY raises $138M to push forward ALS program
VectorY Therapeutics has secured $138 million in a series A financing that will help the Dutch biotech advance its preclinical lead program in ALS.
Gabrielle Masson
Nov 13, 2023 10:26am
Seagen finally finds new CEO—Chutes & Ladders
Nov 11, 2022 9:30am
VectorY raises $38M to develop Alzheimer's, ALS gene therapies
Jun 15, 2021 7:40am
